Skip to main content
. 2009 Jan 12;53(4):1338–1343. doi: 10.1128/AAC.01389-08

FIG. 3.

FIG. 3.

Average PA-824 plasma concentration-versus-time curves (log scale) after administration of PA-824 as the following treatments and at the indicated doses: i.v. solution (IV) at 20 mg/kg; oral mixed micelle suspension (Oral) at 40 mg/kg; and insufflated (Insuff) PA-824 dry powder porous particles at 20, 40, and 60 mg/kg. Values are mean ± standard deviations (n = 6 or 7).